CASE COMMENTS: MERGERS - EUROPEAN UNION - WORKING GROUP - PHARMACEUTICAL SECTOR

Mergers: The European Commission forms a Multilateral Working Group with leading competition authorities to exchange best practices on pharmaceutical mergers

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. In a press release dated 16 March 2021, the European Commission ["Commission"] announced the establishment, together with several other competition authorities, of a multilateral working group to analyse the effects of mergers in the pharmaceutical sector. In addition to the Commission's Directorate General for Competition, the working group will include the Federal Trade Commission ["FTC"], which initiated the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

David Tayar, Emily Xueref-Poviac, Mergers: The European Commission forms a Multilateral Working Group with leading competition authorities to exchange best practices on pharmaceutical mergers, 16 March 2021, Concurrences N° 2-2021, Art. N° 100544, p. 124

Visites 47

All reviews